Idiopathic Membranous Nephropathy Clinical Trials

A listing of Idiopathic Membranous Nephropathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
A Phase III Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients With Primary Membranous Nephropathy

This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics (PK) of obinutuzumab compared with tacrolimus in participants with primary membranous nephropathy (pMN).

  • 5 views
  • 20 Oct, 2022
  • 57 locations
Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

The purpose of this study is to evaluate the efficacy and safety of SHR1459 tablets in patients with primary membranous nephropathy.

  • 0 views
  • 04 Oct, 2022
  • 15 locations
A Randomized, Open-label, Two Arm, Parallel Group, Proof-of-concept Clinical Trial to Investigate the Efficacy and Safety of LNP023 Compared With Rituximab in the Treatment of Subjects With Idiopathic Membranous Nephropathy

membranous nephropathy (MN) who are at high risk of disease progression defined on the basis of antibody anti-PLA2R titre and proteinuria.

proteinuria
kidney biopsy
rituximab
diuretics
lnp023
  • 30 views
  • 20 Oct, 2022
  • 32 locations
Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

This study is a Phase 1b/2a, open-label, sequential-cohort, dose escalation, and dose expansion study to evaluate the safety, tolerability, PK, and PD of VB119 in subjects with primary MN

nephropathy
follicle stimulating hormone
proteinuria
kidney biopsy
monoclonal antibodies
  • 6 views
  • 04 Oct, 2022
  • 16 locations
Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (ITN080AI) (REBOOT)

participants with PM. Background Primary membranous nephropathy (MN) is among the most common causes of nephrotic syndrome in adults. MN affects individuals of all ages

autoimmune diseases
monoclonal antibodies
arthritis
cancer
mammogram
  • 340 views
  • 13 Oct, 2022
  • 11 locations
Obinutuzumab in Primary MN (ORION)

Primary membranous nephropathy (MN) is an antibody-mediated autoimmune glomerular disease, that represents one of the most frequent causes of nephrotic syndrome in adults. The first-generation

remission
nephropathy
proteinuria
rituximab
kidney biopsy
  • 0 views
  • 04 Oct, 2022
  • 2 locations
Studies of Immunologically-Mediated Kidney Diseases

Kidney diseases related to the immune system include, nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with connective tissue disorders

membranous nephropathy
autoimmune diseases
nephropathy
nephritis
glomerulonephritis
  • 230 views
  • 20 Oct, 2022
  • 1 location
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. (Prepare-NS)

Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used to develop a survey to use when testing …

swelling
nephrotic syndrome
kidney transplant
nephropathy
glomerular filtration rate
  • 0 views
  • 04 Oct, 2022
  • 1 location